Healthcare -
Biotechnology - NASDAQ - US
$ 118.0
0.803 %
$ 11.3 B
Market Cap
76.62
P/E
SRPT - ACCOUNTS PAYABLE
Accounts Payable SRPT - Sarepta Therapeutics, Inc.
165 M
LAST VALUE
46.60%
2 YEAR CAGR
37.28%
5 YEAR CAGR
25.05%
10 YEAR CAGR